StockData
Oruka Therapeutics, Inc. logo

Oruka Therapeutics, Inc. (ORKA) stock

ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$105.35+0.36 (+0.34%)

Close on Nov 13, 2026Market cap $6.98BP/E –Yield –

Oruka Therapeutics statistics

64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Aug 29, 2024
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$6.98B
$275.32M
Enterprise Value
$6.05B
$144.91M
PB Ratio
5.83
2.01
P/TBV Ratio
5.83
2.22

Share statisticsIndustry

Shares Change (QoQ)
10.1%
0.49%
Float
35M
49M
Shares Held by Insiders
47.7%
11.6%
Shares Held by Institutions
112.0%
56.4%

Short sellingIndustry

Short Interest
6M
–
Short Interest Change
5.76%
-0.80%
Short % of Float
18.7%
8.98%
Short % of Shares Outstanding
9.76%
6.30%
Days to Cover
7.06
5.16

Stock price statisticsIndustry

52-Week High
$115.52
–
52-Week Low
$25.23
–
20-Day Moving Average
$94.86
–
50-Day Moving Average
$89.68
–
200-Day Moving Average
$72.65
–
Average True Range (14)
$5.66
–
Price Change (1 Week)
2.42%
-1.15%
Price Change (1 Month)
42.6%
-4.86%
Price Change (3 Months)
-6.49%
-21.1%
Price Change (6 Months)
70.1%
-20.7%
Price Change (YTD)
247.6%
-23.6%
Price Change (1 Year)
272.3%
-22.7%
Price Change (3 Years)
398.8%
-29.5%
Price Change (5 Years)
255.4%
-77.8%
Price Change (10 Years)
-80.3%
-65.4%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
998,113
–
Average Volume (90 Days)
921,143
–
Relative Volume
0.74
0.70
Relative Strength Index (14)
64.4
43.4
Volatility (1 Year)
69.3%
80.1%
Beta (5 Years)
0.50
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-18.1%
-50.3%
Return on Assets (ROA)
-17.5%
-40.6%
Return on Invested Capital (ROIC)
-69.8%
-33.1%
Return on Capital Employed (ROCE)
-15.3%
-38.0%

Financial positionIndustry

Current Ratio
29.62
3.30
Quick Ratio
28.96
2.39

EfficiencyIndustry

Profits Per Employee
-$2.24M
-$690.06K
Employee Count
68
75
WACC
7.62%
10.2%

Income statement (TTM)Industry

Operating Income
-$183.11M
-$21.40M
Net Income
-$152.57M
-$22.39M
EBITDA
-$183.11M
-$17.04M

Balance sheetIndustry

Net Cash (Debt)
$920.28M
$17.80M
Net Cash Per Share
$13.90
$0.80
Equity (Book Value)
$1.20B
$53.27M
Book Value Per Share
$18.08
$1.50
Tangible Book Value
$1.20B
$26.82M
Working Capital
$909.71M
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
-$123.64M
-$12.35M
Capital Expenditures
-$219.00K
-$1.00M
Free Cash Flow
-$123.86M
-$18.21M
FCF Per Share
-$1.87
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-2.19%
-22.0%
FCF Yield
-1.78%
-9.44%
Buyback Yield
-0.16%
-0.76%
Shareholder Yield
-0.16%
0.00%

Scores and fair valueIndustry

Altman Z-Score
123.59
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodORKAS&P 500DifferenceORKA per yearS&P 500 per year
1 month+34.7%-3.0%+37.8 pts
3 months-2.6%-2.8%+0.2 pts
Year to date+247.6%+11.5%+236.1 pts
1 year+299.4%+13.5%+285.9 pts
3 years+817.0%+77.7%+739.3 pts+109.3%+21.1%
5 years+560.8%+72.6%+488.2 pts+45.9%+11.5%
10 years-61.4%+308.2%−369.6 pts-9.1%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M ORKA shares were sold short on Oct 30, 2026, up 5.8% from the previous report, or 18.67% of the shares available to trade. At recent volumes it would take 7.1 days to buy them back. Over the last 20 sessions, 53.5% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20266,464,212+5.8%915,0657.1
Oct 15, 20266,112,214-21.4%841,4067.3
Sep 30, 20267,778,131+2.0%1,230,3366.3
Sep 15, 20267,623,327-2.2%656,68611.6
Aug 31, 20267,793,678-6.1%840,4759.3
Aug 14, 20268,303,245+3.1%732,73611.3
Jul 31, 20268,051,704-8.8%961,1648.4
Jul 15, 20268,833,223-3.6%1,415,1146.2
Jun 30, 20269,160,848+32.8%2,137,0204.3
Jun 15, 20266,896,890+8.2%1,134,4086.1
May 29, 20266,373,113+1.9%1,283,1355.0
May 15, 20266,251,854-10.6%1,750,1713.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?